Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for GBLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 -0.01M
March 31, 2024 0.0178M
December 31, 2023 -0.0333M
September 30, 2023 -0.2202M
June 30, 2023 0.00
March 31, 2023 1.625M
December 31, 2022 -0.03M
September 30, 2022 -1.47M
June 30, 2022 -0.125M
March 31, 2022 -0.0761M
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 -0.0627M
March 31, 2021 -0.8506M
December 31, 2020 -0.0887M
September 30, 2020 0.0151M
June 30, 2020 -0.1512M
March 31, 2020 -0.3804M
December 31, 2019 -0.3554M
September 30, 2019 -0.6743M
June 30, 2019 -0.6549M
March 31, 2019 -1.619M
December 31, 2018 -0.4528M
Date Value
September 30, 2018 -4.875M
June 30, 2018 -3.496M
March 31, 2018 -7.20M
December 31, 2017 0.0046M
September 30, 2017 0.00
June 30, 2017 -0.0045M
March 31, 2017 -4.609M
December 31, 2016 -0.9998M
September 30, 2016 -2.847M
June 30, 2016 -1.294M
March 31, 2016 -0.1018M
December 31, 2015 -0.2048M
September 30, 2015 0.1351M
June 30, 2015 -1.308M
March 31, 2015 -0.4939M
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 -3.580M
March 31, 2014 -0.6848M
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 0.00
CNBX Pharmaceuticals, Inc. 0.00
Arvinas, Inc. -0.50M
Fulcrum Therapeutics, Inc. -0.356M
Definium Therapeutics, Inc. -758.70M